Abdou Salam Poutougnigni: Honored to Represent Fondation Pierre Fabre at the Africa CDC Sickle Cell Disease Validation Conference
Abdou Salam Poutougnigni, General Coordinator (Multi-country) at the Fondation Pierre Fabre, shared a post on LinkedIn:
“Honored to represent Fondation Pierre Fabre at the International Conference on the Validation and Launch of the Africa CDC Continental Plan for Sickle Cell Disease (SCD) and other Rare Blood Disorders, taking place in Uganda from 11–13 May 2026.
This important gathering brings together African Union Member States, technical working groups, NGOs, foundations, healthcare professionals, researchers, and warriors’ associations around a shared commitment: strengthening continental coordination and advancing equitable access to comprehensive care for people living with sickle cell disease and other rare blood disorders across Africa.
The validation and launch of this continental framework marks an important step toward stronger policies, improved screening and diagnosis, better access to treatment, community engagement, and sustainable partnerships for impact.
I am grateful for the opportunity to contribute to these strategic discussions and to collaborate with dedicated stakeholders working to improve the lives of patients and families across the continent.”

Stay updated with Hemostasis Today.
-
May 12, 2026, 14:42Suleiman Malhi at Sundas Foundation with Blood Donation Society on the occasion of World Thalassemia Day
-
May 12, 2026, 14:39Neil Blumberg: Why Washed Red Cell and Platelet Transfusions Deserve More Attention
-
May 12, 2026, 14:34Wajeeha Rashid: Research Poster Award at MedExpo 2.0
-
May 12, 2026, 14:27Intezar Mehdi: When Frequent Nosebleeds Are Not Just a Minor Issue
-
May 12, 2026, 14:22Understanding the Human Side of Hemophilia Gene Therapy – ISTH
-
May 12, 2026, 14:01Moses Wasswa: Tackling Sickle Cell Disease in Uganda
-
May 12, 2026, 13:58Arun Chervu: Most DVT Patients Do Well on Anticoagulation Alone
-
May 12, 2026, 13:49Shashank Joshi: Antiphospholipid Antibodies and Risk of Thrombotic Cardiovascular Events
-
May 12, 2026, 13:44Hayley Evans: Variability in Perioperative TXA Practice Despite Strong Evidence